VALERIE FERRARA: Open Payments
NPI 1861729824 · PALM CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,682 in 110 payments from 22 companies in 2025. Trend: 2023 $2,290 · 2024 $5,125 · 2025 $2,682
Food & beverage: $2,682
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $353 |
| Otsuka America Pharmaceutical, Inc. | 6 | $337 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $314 |
| Axsome Therapeutics, Inc. | 10 | $256 |
| Collegium Pharmaceutical, Inc. | 11 | $169 |
| Corium, LLC | 10 | $168 |
| Braeburn Inc. | 2 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $133 |
| Alkermes, Inc. | 7 | $133 |
| Janssen Pharmaceuticals, Inc | 5 | $110 |
Products named: REXULTI, VRAYLAR, CAPLYTA, Auvelity, Jornay PM, Azstarys, BRIXADI, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
